Polly David W, Glassman Steven D, Schwender James D, Shaffrey Christopher I, Branch Charles, Burkus J Kenneth, Gornet Matthew F
Department of Orthopaedic Surgery, University Minnesota, Minneapolis, MN 55454, USA.
Spine (Phila Pa 1976). 2007 May 15;32(11 Suppl):S20-6. doi: 10.1097/BRS.0b013e318053d4e5.
A retrospective review of prospectively collected data.
To review systematically the SF-36 PCS outcomes of a large data set, including several randomized clinical trials for lumbar spine fusion at 1 and 2 years after surgery. We also present for comparison a review of typical changes in SF-36 PCS in other surgical interventions (total knee replacement, total hip replacement, and coronary artery bypass surgery) to define the average reimbursement costs per PCS improvement with each of these interventions.
Data from 11 prospective multicenter studies (9 Food and Drug Administration Investigational Device Exemption, Randomized Prospective Clinical Trials, class 1 data) accounted for the lumbar spine fusion group (n = 1826). Data for total knee replacement, total hip replacement, and coronary artery bypass surgery were obtained from a comprehensive review of the literature.
Comparisons of SF-36 PCS improvements were made at defined postoperative time points and with published study findings of other medical conditions. Reimbursement estimates (not including estimated physician and rehabilitation fees) for each surgical intervention were based on Centers for Medicare and Medicaid Services Medicare Provider Analysis and Review and All Payer Data (2002). Cost estimates were calculated for a minimal clinical important improvement (reimbursement dollars/mean PCS change *5.42 point PCS improvement).
SF-36 PCS significantly improved at both 1 and 2 years following lumbar spine fusion surgery (P < 0.0001), and was comparable to the control surgical outcomes. With the use of data from Centers for Medicare and Medicaid Services Medicare Provider Analysis and Review and All Payer Data, hospital reimbursement averaged $15.2-18.2K for lumbar spine fusion, $9.8-11.3K for total knee replacement, $9.6-11.3K for total hip replacement, and $9.8-11.3K for coronary artery bypass surgery. Calculations of reimbursement dollars to elicit minimum clinically important change in PCS of 5.42 points following surgery ranged from $6.1 to $7.3K for lumbar spine fusion, $5.7 to $6.6K for total knee arthroplasty, $3.9 to $4.5K for total hip replacement, and $18.2 to $22.5K for coronary artery bypass surgery.
While the exact numbers may vary for each treatment based on the population studied and the cost estimates used, lumbar fusion cost per benefit achieved was very comparable to other well-accepted medical interventions (total hip replacement, total knee replacement, and coronary artery bypass surgery).
对前瞻性收集的数据进行回顾性分析。
系统回顾一个大数据集的SF-36生理功能分量表(PCS)结果,包括多项腰椎融合术的随机临床试验在术后1年和2年的结果。我们还给出其他外科手术干预(全膝关节置换术、全髋关节置换术和冠状动脉搭桥手术)中SF-36 PCS的典型变化回顾以作比较,从而确定这些干预措施中每改善一个PCS所对应的平均报销费用。
11项前瞻性多中心研究的数据(9项美国食品药品监督管理局研究器械豁免、随机前瞻性临床试验,1类数据)构成了腰椎融合术组(n = 1826)。全膝关节置换术、全髋关节置换术和冠状动脉搭桥手术的数据来自对文献的全面回顾。
在规定的术后时间点比较SF-36 PCS的改善情况,并与其他疾病的已发表研究结果进行比较。每种外科手术干预的报销估算(不包括估算的医生和康复费用)基于医疗保险和医疗补助服务中心的医疗保险提供者分析与审查以及所有支付者数据(2002年)。计算最小临床重要改善的费用估算(报销金额/平均PCS变化×5.42分的PCS改善)。
腰椎融合术后1年和2年,SF-36 PCS均显著改善(P < 0.0001),且与对照手术结果相当。利用医疗保险和医疗补助服务中心的医疗保险提供者分析与审查以及所有支付者数据,腰椎融合术的医院报销平均为15200 - 18200美元,全膝关节置换术为9800 - 11300美元,全髋关节置换术为9600 - 11300美元,冠状动脉搭桥手术为9800 - 11300美元。计算术后PCS获得5.42分最小临床重要变化所需的报销金额,腰椎融合术为6100 - 7300美元,全膝关节置换术为5700 - 6600美元,全髋关节置换术为3900 - 4500美元,冠状动脉搭桥手术为18200 - 22500美元。
虽然基于所研究的人群和所使用的费用估算,每种治疗的确切数字可能有所不同,但腰椎融合术每获得一份益处的成本与其他公认的医疗干预措施(全髋关节置换术、全膝关节置换术和冠状动脉搭桥手术)非常相近。